The International Agency for Research on Cancer found that approximately 14.1 million cancer cases were diagnosed in 2012 and is expected to reach 21.7 million by 2030 across the world. This shows that the demand for therapeutics biologics is likely to increase, further propelling demand for virus filtration products. Spurred by this, the global virus filtration market is expected to grow in the forthcoming years. The adoption of virus filtration technology is likely to increase, mainly for the purification of biopharmaceutical products.
Pall Corporation to Launch a New Business Unit New to Strengthen its Market Position
The report highlights in-depth analysis of leading companies operating in the global virus filtration market. Some of the big players are mentioned below:
- Asahi Kasei Medical Co. Ltd.
- General Electric Company
- Danaher Corporation
- Sartorius AG
- Clean Cell Inc.
- Wuxi Biologics
- Thermo Fischer Scientific Inc.
- Lonza Group Ltd
- Charles River Laboratories International Inc
These companies have a robust distribution network and offer advanced virus filters across the world. For instance, Sartorius has around 30 sales offices and is present in over 110 countries worldwide. As per the American Cancer Society, around 1,70,000 new cases of cancer are projected to be diagnosed in the year 2019. The adoption of virus removal products is expected to increase for the development of innovative therapeutics of chronic diseases.
Some of the companies are putting efforts to adopt different strategies in order to strengthen their market position. For instance, Pall Corporation announced the launch of a new biotech business unit called Pall Biotech. This new unit aims to focus on developing biological products and virus filtration products.
Fortune Business Insights offers a detailed overview of the global virus filtration market in a report, titled “Market Size, Share and Global Trend By Product (Consumables, Instruments, Services), By Application (Biologicals, Medical devices, Water Purification, Air Filtration, Others), By End-User (Hospitals and Clinics, Pharmaceutical Companies, Medical Device Companies, Contract Testing Organizations) and Geography Forecast till 2026.” The report tracks market dynamics which include drivers, restraints, and opportunities. It offers market share, value, growth as per segment, and uses qualitative and quantitative methods to make forecasts for regions. Aimed to provide insights into the competitive landscape, the report analyses data and gathers information from several primary and secondary sources.
India’s Biopharmaceutical Industry to Cross US$ 100 Billion by 2025, Driving the Market in Asia Pacific
North America is projected to maintain its dominance in the global virus filtration market through the forecast years. The increasing adoption of virus filtration products in biopharmaceutical and medical sectors is the primary factor driving the market in this region. Europe is anticipated to create huge growth opportunities for the virus filtration market on account of the rising number of research activities.
As per the Indian Brand Equity Foundation, the biopharmaceutical industry in India is projected to reach US$ 100 billion by 2025. Considering this, the demand for virus filters is expected to surge, thereby impacting the virus filtration market size in Asia Pacific. Furthermore, the adoption of virus filtration technology is likely to increase owing to the rising improvements in healthcare infrastructure.
More Trending Topics From Fortune Business [email protected]